Amphastar Pharmaceuticals (AMPH) Current Taxes (2016 - 2026)
Amphastar Pharmaceuticals has reported Current Taxes over the past 13 years, most recently at $239000.0 for Q4 2025.
- For Q4 2025, Current Taxes fell 97.53% year-over-year to $239000.0; the TTM value through Dec 2025 reached $239000.0, down 97.53%, while the annual FY2025 figure was $239000.0, 97.53% down from the prior year.
- Current Taxes for Q4 2025 was $239000.0 at Amphastar Pharmaceuticals, down from $5.6 million in the prior quarter.
- Over five years, Current Taxes peaked at $31.1 million in Q3 2023 and troughed at $239000.0 in Q4 2025.
- A 5-year average of $7.1 million and a median of $4.3 million in 2021 define the central range for Current Taxes.
- Biggest five-year swings in Current Taxes: soared 2864.15% in 2023 and later crashed 97.53% in 2025.
- Year by year, Current Taxes stood at $9.1 million in 2021, then plummeted by 49.66% to $4.6 million in 2022, then tumbled by 64.8% to $1.6 million in 2023, then surged by 500.62% to $9.7 million in 2024, then crashed by 97.53% to $239000.0 in 2025.
- Business Quant data shows Current Taxes for AMPH at $239000.0 in Q4 2025, $5.6 million in Q3 2025, and $1.0 million in Q2 2025.